Edition:
United Kingdom

Cellectis SA (ALCLS.PA)

ALCLS.PA on Paris Stock Exchange

11.20EUR
16 Aug 2019
Change (% chg)

€0.52 (+4.87%)
Prev Close
€10.68
Open
€10.66
Day's High
€11.28
Day's Low
€10.66
Volume
23,724
Avg. Vol
55,588
52-wk High
€25.96
52-wk Low
€10.06

About

Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development and commercialization of rational genome engineering technologies. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid... (more)

Overall

Beta: 1.96
Market Cap(Mil.): €569.92
Shares Outstanding(Mil.): 42.45
Dividend: --
Yield (%): --

Financials

  ALCLS.PA Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -1.51 -- --
ROI: -23.23 7.52 12.69
ROE: -21.28 7.94 17.13

BRIEF-Cellectis Reports New CAR Design To Control T-Cells

* REPORTED ON MONDAY NEW CAR DESIGN TO CONTROL CAR T-CELLS IN NON-LETHAL WAY

09 Jul 2019

BRIEF-Cellectis Q4 Operating Loss Widens To 29.3 Million Dollars

* ANNOUNCED ON MONDAY, CELLECTIS REPORTS 4TH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS

12 Mar 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates